drug-eluting stent

(redirected from Drug eluting stent)
Also found in: Acronyms, Wikipedia.

drug-eluting stent

Abbreviation: DES
A stent coated with medications that it releases into surrounding intimal cells. It is designed to keep the lumen of an artery from closing both by holding the artery open and by retarding the growth of the vascular endothelium into the stent. See: bare metal stent
See also: stent
References in periodicals archive ?
Part V: Drug eluting stent cytostatic effect is active (drug) 100% absorbable coating polymermatrixban 50 pieces.
Boston Scientific Introduces Taxus Liberte Drug Eluting Stent
They found that mortality in the first 30 days for people with drug eluting stents was significantly lower than for those with bare metal stents.
4 Part bid round coronary drug eluting stent IV / Quantity 50;.
Segment - Bare Metal and Drug Eluting Stent Markets
The growth in the demand for the Drug Eluting Stent is due to its increasing acceptance as a viable treatment.
This strengthens MIVT's growing reputation for scientific leadership as we continue on our path to commercialization and address the market's demand for a safer drug eluting stent.
With today's release, SurModics has announced the signing of license agreements with eight different companies to incorporate SurModics technologies on their drug eluting stent products.
TLR is the rate of re-treatment of patients after coronary stenting and is widely viewed by physicians as an important clinical marker of drug eluting stent effectiveness.
Bob Dutcher, President and CEO of Possis Medical, manufacturer of the AngioJet(R) Rheolytic(TM) Thrombectomy System used to treat the Thoraxcentre patients said, "These results are important to interventionalists and their patients with acute myocardial infarction treated with drug eluting stents.

Full browser ?